Birth Control Pills Recalled

More than 92,000 cartons of Tri-Lo-Sprintec tablets are being recalled by Teva Pharmaceuticals USA because samples of the drug failed to meet dissolution specifications during testing, according to the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report.

The recall affects Tri-Lo-Sprintec (norgestimate and ethinyl estradiol) tablets, packaged in cartons (NDC 0093-2140-62) containing three 28-tablet blister cards, from lots 100039678 (Exp. 4/30/24), 100038111 (Exp. 7/31/24), and 100042277 (Exp. 7/31/24). The cartons were distributed nationwide. Teva Pharmaceuticals USA voluntarily initiated the recall on March 7, 2024. The FDA designated the recall a Class II on March 28, 2024. The classification communicates use of tablets may cause temporary or medically reversible adverse health consequences, or a remote possibility of serious harm.

Tri-Lo-Sprintec is a prescription oral contraceptive.